Safety

News

Boehringer Ingelheim, Biberach, Germany, February 2007

Boehringer sells drug safety software to ArisGlobal

German drugmaker Boehringer Ingelheim has sold an artificial intelligence-powered software platform it developed to monitor drug safety data to ArisGlobal, which provides cloud software to

News

Astellas takes $170m charge as it drops DMD gene therapies

Astellas has said it will book a $170 million impairment charge in its fourth quarter results as a result of a decision to halt the development of three gene therapy candidates for Duchenne

News

Gilead cleared to restart trials of CD47 drug magrolimab

Gilead Sciences can restart pivotal trials of its cancer antibody magrolimab – the centrepiece of its $4.9 billion

News

Digital innovation drives vaccine development

COVID vaccines not linked to excess deaths, says CDC

There is no evidence that vaccination with either the Pfizer/BioNTech or Moderna's mRNA-based COVID-19 vaccines led to the death of patients, says a study by researchers at the Centres for

News